COO vs REPL · P/E 36, rev $4.09B vs $825.7M cap
The Cooper Companies, Inc (COO) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. Revenue was up 5.1% from 2024-10-31 to 2025-10-31. COO currently screens at market cap $14.92B and trailing P/E 36.1.
REPL does not have a complete income-statement cache yet.
COO currently screens at market cap $14.92B and trailing P/E 36.1. REPL currently screens at market cap $825.7M.
Not investment advice. Open the COO and REPL stock pages for the full models.
Not investment advice.